Target intelligence / Profile preview

Intermediate filament family orphan 1 (IFFO1)

Target
IFFO1
Molecular classification
Structural protein, Intermediate filament family, Nuclear matrix protein, Other
01

Overview

Intermediate filament family orphan 1 (IFFO1) is a structural protein of the intermediate filament family, encoded by the IFFO1 gene in humans. It is primarily associated with the cytoskeleton and nuclear envelope across various eukaryotic cell types[1][4]. IFFO1 acts as a nuclear matrix protein and is involved in immobilizing broken DNA ends, reducing chromosome translocation during DNA double-strand break (DSB) repair. The protein is recruited to sites of DNA damage in an XRCC4-dependent manner and forms a complex with XRCC4 and lamin A/C to create a nucleoskeleton, thereby stabilizing DNA ends and suppressing genome instability, particularly during tumorigenesis[2][4][5]. IFFO1 is widely expressed, with highest levels in the spleen, cerebellum, and cerebral cortex, and has several spliced isoforms. While structurally similar to vimentin, IFFO1 is evolutionarily conserved in vertebrates and possesses numerous post-translational modifications. There is currently no evidence implicating IFFO1 as a direct therapeutic drug target, nor are there clinically significant interacting drugs, biomarker applications, or described safety concerns.

Other names
IFFO1HOM-TES-103IFFOIntermediate filament family orphan 1Intermediate filament family orphan isoform X1Intermediate filament-like MGC:2625Tumor antigen HOM-TES-103Non-homologous end joining factor IFFO1NHEJ factor IFFO1
02

Biological functions

DNA double-strand break repairNon-homologous end joiningChromosomal stabilityCytoskeletal organizationScaffold assemblyNuclear envelope integrity
03

Disease associations

Potential role in cancer (linked to chromosome translocation susceptibility)Other

Beyond the preview

Go deeper on Intermediate filament family orphan 1 (IFFO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intermediate filament family orphan 1 (IFFO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call